The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Auris Nasus Larynx
- Vol. 48 (5) , 885-889
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated VasculitisNew England Journal of Medicine, 2014
- Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trialsRheumatology, 2014
- Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in JapanRheumatology International, 2014
- Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated VasculitisAllergology International, 2014
- Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in JapanClinical and Experimental Nephrology, 2012
- Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV studyModern Rheumatology, 2012
- Otologic Symptoms as Initial Manifestation of Wegener GranulomatosisOtology & Neurotology, 2011
- New pathophysiological insights and treatment of ANCA-associated vasculitisKidney International, 2011
- Pathogenesis of Vascular Inflammation by Anti-Neutrophil Cytoplasmic AntibodiesJournal of the American Society of Nephrology, 2006
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985